Weight Loss Drugs May Reduce Alcohol Consumption in Alcohol Use Disorder
A new study has found that weight loss drugs may significantly reduce the consumption of alcohol in those with alcohol use disorder.
FDA adds new warning to weight loss drugs
The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a higher risk of inhaling gastric contents into their lungs while under
Weight-loss drugs replacing some surgeries, but doctors say they're 'not a miracle drug'
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.
Take a look at a dieter’s weight loss journey using Ozempic
People who take popular weight loss drugs like Ozempic can have serious side effects and new research says stopping them can also cause problems. Now that millions of people have successfully lost weight using them,
Do Weight Loss Drugs Like Ozempic Affect Your Breast Health?
Medically reviewed by Danielle Weiss, MD After losing extra pounds on Ozempic (semaglutide), some are finding themselves dealing with an unexpected issue, what's become known as "Ozempic breasts." This possible side effect of glucagon-like peptide 1 (GLP-1) agonist medication users like Ozempic,
New weight loss drug could be a 'better Ozempic'
Weather conditions complicating efforts to get New Jersey wildfire under control Deion Sanders imposed harsh punishment on Colorado players after they disregarded his game plan Princess Kate Revived Queen Elizabeth’s Remembrance Day Tradition The unhealthiest fast-food sandwich in America isn't a Big Mac,
Mimic Ozempic’s Weight Loss Effects Naturally With a Keto-Based Diet
Everyone is raving about the slimming power of semaglutide medications like Ozempic and Wegovy, which experts say is as effective as weight loss surgery. While it’s not for everyone, it can be a lifesaving option for some.
Compounded GLP-1s for Weight Loss: What Are They and Are They Safe?
GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...
Investigating the effect of treatment with GLP-1 receptor agonists on muscle mass
Recent studies have shown that pharmacological treatment with GLP-1-RA and dual GLP-1/glucose-dependent insulinotropic ...
Health.com7d
Struggling to Lose Weight on Obesity Drugs? Here's What You Need to Know
By now, stories of people achieving their weight loss goals while taking Ozempic, Zepbound, or other GLP-1 receptor agonists abound—but that doesn’t mean everyone will shed pounds on these ...
4 Ways to Prevent Muscle Loss on Ozempic & Other Weight Loss GLP-1 Medications
You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...
MedPage Today on MSN3d
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss Drugs
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
Nutrition Business Journal Releases Special Report on Supplements in the Age of GLP-1 Agonists
BOULDER, CO / ACCESSWIRE / / Informa Market's New Hope Network and Nutrition Business Journal (NBJ) unveil a special report ...
TCTMD2d
Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key
In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1) receptor agonists ... primarily ...
UPI9d
Medicaid covers GLP-1 weight-loss drugs in just 13 states
Poorer folks' access to blockbuster weight-loss drugs through Medicaid remains ... treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered.
New Atlas4d
Weight-loss pill passes important safety test in clinical trial
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
FierceBiotech2d
High-flying Metsera follows phase 1 weight loss data with $215M series B raise
The biotech said it would use the cash to “further accelerate” a portfolio led by its GLP-1 receptor agonist MET-097 ...